{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:56:05Z","timestamp":1786985765601,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Lieselotte Beutel Stiftung"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.cbi.2017.10.007","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T12:15:30Z","timestamp":1507724130000},"page":"179-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Deciphering molecular mechanisms of arginine deiminase-based therapy \u2013 Comparative response analysis in paired human primary and recurrent glioblastomas"],"prefix":"10.1016","volume":"278","author":[{"given":"Claudia","family":"Maletzki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Rosche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin","family":"Riess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7824-5073","authenticated-orcid":false,"given":"Doreen","family":"William","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl Friedrich","family":"Classen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Kreikemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8054-1402","authenticated-orcid":false,"given":"Michael","family":"Linnebacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Fiedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2017.10.007_bib1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ijc.30051","article-title":"Molecular basis and current strategies of therapeutic arginine depletion for cancer","volume":"139","author":"Fultang","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cbi.2017.10.007_bib2","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1158\/1078-0432.CCR-14-2610","article-title":"Phase I trial of arginine deprivation therapy with ADI-PEG 20 plus docetaxel in patients with advanced malignant solid tumors","volume":"21","author":"Tomlinson","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cbi.2017.10.007_bib3","doi-asserted-by":"crossref","first-page":"e0171985","DOI":"10.1371\/journal.pone.0171985","article-title":"Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma","volume":"12","author":"Liu","year":"2017","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.cbi.2017.10.007_bib4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/ijms17030363","article-title":"Arginine metabolism in bacterial pathogenesis and cancer therapy","volume":"11","author":"Xiong","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2017.10.007_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/jgh.12043","article-title":"Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma","volume":"28","author":"Wu","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2017.10.007_bib6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10637-012-9862-2","article-title":"Phase I\/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma","volume":"31","author":"Ott","year":"2013","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.cbi.2017.10.007_bib7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1755-148X.2010.00798.x","article-title":"Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis","volume":"24","author":"Lam","year":"2011","journal-title":"Pigment. Cell Melanoma Res."},{"key":"10.1016\/j.cbi.2017.10.007_bib8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bbrc.2009.08.007","article-title":"Activation of autophagy during glutamate-induced HT22 cell death","volume":"388","author":"Kim","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2017.10.007_bib9","doi-asserted-by":"crossref","first-page":"37694","DOI":"10.18632\/oncotarget.17032","article-title":"Arginine deiminase expressed in vivo, driven by human telomerase reverse transcriptase promoter, displays high hepatoma targeting and oncolytic efficiency","volume":"8","author":"Jiang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2017.10.007_bib10","doi-asserted-by":"crossref","first-page":"e1542","DOI":"10.7717\/peerj.1542","article-title":"L-Canavanine potentiates the cytotoxicity of doxorubicin and cisplatin in arginine deprived human cancer cells","volume":"4","author":"Nurcahyanti","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.cbi.2017.10.007_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2015.04.020","article-title":"Targeting arginine metabolism pathway to treat arginine-dependent cancers","volume":"364","author":"Qiu","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2017.10.007_bib12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jamaoncol.2016.3049","article-title":"Arginine deprivation with pegylated arginine deiminase in patients with argininosuccinate synthetase 1-deficient malignant pleural mesothelioma: a randomized clinical trial","volume":"3","author":"Szlosarek","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.cbi.2017.10.007_bib13","article-title":"Phase 1 dose-escalation study of pegylated arginine deiminase, cisplatin, and pemetrexed in patients with argininosuccinate synthetase 1-deficient thoracic cancers","volume":"7","author":"Beddowes","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cbi.2017.10.007_bib14","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1200\/JCO.2012.42.1784","article-title":"Metabolic response to pegylated arginine deiminase in mesothelioma with promoter methylation of argininosuccinate synthetase","volume":"31","author":"Szlosarek","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cbi.2017.10.007_bib15","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.18632\/oncotarget.3370","article-title":"Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin","volume":"6","author":"Savaraj","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2017.10.007_bib16","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1080\/15384047.2015.1026478","article-title":"Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo","volume":"16","author":"Fiedler","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.cbi.2017.10.007_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pep.2013.07.002","article-title":"Kinetic characterization of arginine deiminase and carbamate kinase from Streptococcus pyogenes M49","volume":"91","author":"Hering","year":"2013","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.cbi.2017.10.007_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-3-319-12048-5_4","article-title":"Radiation therapy of glioblastoma","volume":"163","author":"Barani","year":"2015","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.cbi.2017.10.007_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.biocel.2006.10.007","article-title":"Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2","volume":"39","author":"Mavri-Damelin","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cbi.2017.10.007_bib20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1021\/acschemneuro.6b00253","article-title":"HSP47 promotes glioblastoma stemlike cell survival by modulating tumor microenvironment extracellular matrix through TGF-\u03b2 pathway","volume":"8","author":"Jiang","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"10.1016\/j.cbi.2017.10.007_bib21","doi-asserted-by":"crossref","first-page":"e458","DOI":"10.1038\/cddis.2012.197","article-title":"Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma","volume":"17","author":"Syed","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2017.10.007_bib22","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1517\/13543784.2014.934808","article-title":"The role of arginine and the modified arginine deiminase enzyme ADI-PEG 20 in cancer therapy with special emphasis on Phase I\/II clinical trials","volume":"23","author":"Synakiewicz","year":"2014","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.cbi.2017.10.007_bib23","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1158\/1535-7163.MCT-09-0794","article-title":"Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc\/HIF-1alpha\/Sp4","volume":"8","author":"Tsai","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cbi.2017.10.007_bib24","article-title":"Heat-shock proteins","author":"Li","year":"2004","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.cbi.2017.10.007_bib25","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4161\/auto.5.4.8252","article-title":"ADI, autophagy and apoptosis: metabolic stress as a therapeutic option for prostate cancer","volume":"5","author":"Kim","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.cbi.2017.10.007_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00280-012-1983-y","article-title":"Vinorelbine and capecitabine in anthracycline- and\/or taxane-pretreated metastatic breast cancer: sequential or combinational?","volume":"71","author":"Zhang","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"10","key":"10.1016\/j.cbi.2017.10.007_bib27","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1476-4598-10-128","article-title":"Chemoresistance of glioblastoma cancer stem cells\u2013much more complex than expected","volume":"11","author":"Beier","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cbi.2017.10.007_bib28","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1038\/bjc.2014.209","article-title":"Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma","volume":"110","author":"Hottinger","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cbi.2017.10.007_bib29","doi-asserted-by":"crossref","first-page":"126586","DOI":"10.1155\/2014\/126586","article-title":"New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells","volume":"2014","author":"W\u00fcrth","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.cbi.2017.10.007_bib30","first-page":"3487","article-title":"Sorafenib plus daily low-dose temozolomide for relapsed glioblastoma: a phase II study","volume":"33","author":"Zustovich","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cbi.2017.10.007_bib31","doi-asserted-by":"crossref","first-page":"61988","DOI":"10.18632\/oncotarget.11328","article-title":"Sorafenib inhibits cell growth but fails to enhance radio- and chemosensitivity of glioblastoma cell lines","volume":"7","author":"Riedel","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2017.10.007_bib32","first-page":"8","article-title":"Unraveling the anticancer effect of curcumin and resveratrol","author":"Pavan","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.cbi.2017.10.007_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11523-015-0378-5","article-title":"Targeting glioblastoma with the use of phytocompounds and nanoparticles","volume":"11","author":"Pistollato","year":"2016","journal-title":"Target Oncol."},{"key":"10.1016\/j.cbi.2017.10.007_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12885-017-3058-2","article-title":"Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species","volume":"17","author":"Gersey","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cbi.2017.10.007_bib35","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3171\/2016.1.JNS152077","article-title":"Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration","volume":"126","author":"Clark","year":"2017","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.cbi.2017.10.007_bib36","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/2014.12.FOCUS14748","article-title":"Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors","volume":"38","author":"Golden","year":"2015","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.cbi.2017.10.007_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1439","article-title":"Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma","volume":"9","author":"Wadajkar","year":"2017","journal-title":"Wiley Interdiscip. Rev. Nanomed Nanobiotechnol"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279717307871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279717307871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:46:01Z","timestamp":1762112761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279717307871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":37,"alternative-id":["S0009279717307871"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2017.10.007","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering molecular mechanisms of arginine deiminase-based therapy \u2013 Comparative response analysis in paired human primary and recurrent glioblastomas","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2017.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}